Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.
Role of Chlamydia in Multiple Sclerosis.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
A case of post-vaccination optic neuritis: coincidence or causative?
Lack of information about multiple sclerosis in children can impact parents' sense of competency and satisfaction within the couple.
Balance.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Metabolic Control of Th17 Cell Generation and CNS Inflammation.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.
Moral Distress: Recognition, Diagnosis, and Treatment.
Opexa's Tovaxin® for the Treatment of Multiple Sclerosis Granted Fast Track Designation by FDA
Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
An introduction with medical applications to functional data analysis.
Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits.
Sodium channel Nav1.8: Emerging links to human disease.
The Efficacy and Tolerability of Mycophenolate Mofetil in Treating Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Western China.
Looking anew at cognitive dysfunction in multiple sclerosis: The gorilla in the room.
Social support, depression, and physical disability: Age and diagnostic group effects.
Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.
The control of reactive oxygen species production by SHP-1 in oligodendrocytes.
Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica.
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue.
Pages
« first
‹ previous
…
248
249
250
251
252
253
254
255
256
…
next ›
last »